MedPath

Study to assess role of mitomycin c to improve outcome in patients of biliary atresia after portoenterostomy surgery.

Not Applicable
Completed
Conditions
Health Condition 1: Q442- Atresia of bile ducts
Registration Number
CTRI/2018/12/016495
Lead Sponsor
PGIMER
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
33
Inclusion Criteria

Diagnosed as EXtra hepatic BIliary atresia

Exclusion Criteria

refuse to give consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
-Clearance of jaundice <br/ ><br> -Native liver survival <br/ ><br>- Improvement in liver function testTimepoint: 3 months, 6 months , 1 year
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath